Inactive/Delisted stock
Anebulo Pharmaceuticals Stock (NASDAQ:ANEB)
Previous Close
$3.24
52W Range
$0.80 - $3.42
50D Avg
$1.48
200D Avg
$1.46
Market Cap
$131.06M
Avg Vol (3M)
$362.86K
Beta
-0.99
Div Yield
-
ANEB Company Profile
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.